Considerations for Causality Assessment of Neurological and Neuropsychiatric Complications of SARS-CoV-2 Vaccines: from Cerebral Venous Sinus Thrombosis to Functional Neurological Disorder

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2021 Aug 7

PMID 34362855

Citations 34

Authors

Matt Butler

Arina Tamborska

Greta K Wood

Mark Ellul

Rhys H Thomas

Ian Galea

Sarah Pett

Bhagteshwar Singh

Tom Solomon

Thomas Arthur Pollak

Benedict D Michael

Timothy R Nicholson

Affiliations

Soon will be listed here.

Citing Articles

Myelin Oligodendrocyte Glycoprotein G Antibody-Positive Paraneoplastic Myelopathy in Seminoma: A Case Report and Literature Review.

Hamid U, Rissardo J, Alviz L, Caprara A, Franada T Neurohospitalist. 2024; :19418744241288288.

PMID: 39544263 PMC: 11559457. DOI: 10.1177/19418744241288288.

New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature.

Paybast S, Jameie M, Shahbazi M, Habibi M, Mohammadianinejad S, Harirchian M Curr J Neurol. 2024; 23(1):21-38.

PMID: 39431229 PMC: 11489623. DOI: 10.18502/cjn.v23i1.16430.

Myelin oligodendrocyte glycoprotein-associated transverse myelitis after SARS-CoV-2 infection: A case report.

Zheng J, Chang J, Hu J, Lin Z, Lin K, Lu B World J Radiol. 2024; 16(9):446-452.

PMID: 39355395 PMC: 11440270. DOI: 10.4329/wjr.v16.i9.446.

Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study.

Granja Lopez J, Estebas Armas C, Lorenzo Dieguez M, Puertas Munoz I, de Celis Ruiz E, Rigual R Front Pharmacol. 2024; 15:1376474.

PMID: 39175548 PMC: 11338880. DOI: 10.3389/fphar.2024.1376474.

Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study.

Jameie M, Azizmohammad Looha M, Ebadi Z, Amanollahi M, Amani K, Nobahari F BMC Neurol. 2024; 24(1):291.

PMID: 39164636 PMC: 11334504. DOI: 10.1186/s12883-024-03793-y.

References

Butler M, Pollak T, Rooney A, Michael B, Nicholson T . Neuropsychiatric complications of covid-19. BMJ. 2020; 371:m3871. DOI: 10.1136/bmj.m3871. View

. Claims and counterclaims over alleged adverse reaction in covid-19 vaccine in India. BMJ. 2020; 371:m4734. DOI: 10.1136/bmj.m4734. View

Hill A . THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?. Proc R Soc Med. 1965; 58:295-300. PMC: 1898525. DOI: 10.1177/003591576505800503. View

Bartholomew R, Wessely S, James Rubin G . Mass psychogenic illness and the social network: is it changing the pattern of outbreaks?. J R Soc Med. 2013; 105(12):509-12. PMC: 3536509. DOI: 10.1258/jrsm.2012.120053. View

Espay A, Aybek S, Carson A, Edwards M, Goldstein L, Hallett M . Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurol. 2018; 75(9):1132-1141. PMC: 7293766. DOI: 10.1001/jamaneurol.2018.1264. View

Logunov D, Dolzhikova I, Shcheblyakov D, Tukhvatulin A, Zubkova O, Dzharullaeva A . Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275):671-681. PMC: 7852454. DOI: 10.1016/S0140-6736(21)00234-8. View

Pottegard A, Lund L, Karlstad O, Dahl J, Andersen M, Hallas J . Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021; 373:n1114. PMC: 8097496. DOI: 10.1136/bmj.n1114. View

Cao L, Ren L . Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg. 2021; 122(3):793-795. PMC: 7849959. DOI: 10.1007/s13760-021-01608-2. View

Knoll M, Wonodi C . Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2020; 397(10269):72-74. PMC: 7832220. DOI: 10.1016/S0140-6736(20)32623-4. View

10.

Hause A, Gee J, Johnson T, Jazwa A, Marquez P, Miller E . Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(18):685-688. PMC: 9368750. DOI: 10.15585/mmwr.mm7018e3. View

11.

Edwards M, Adams R, Brown H, Parees I, Friston K . A Bayesian account of 'hysteria'. Brain. 2012; 135(Pt 11):3495-512. PMC: 3501967. DOI: 10.1093/brain/aws129. View

12.

Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, Hublin C, Linna M, Olsen P . Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012; 7(3):e33723. PMC: 3314680. DOI: 10.1371/journal.pone.0033723. View

13.

Baltagi S, Shoykhet M, Felmet K, Kochanek P, Bell M . Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med. 2010; 11(2):179-84. DOI: 10.1097/PCC.0b013e3181cf4652. View

14.

Ellul M, Varatharaj A, Nicholson T, Pollak T, Thomas N, Easton A . Defining causality in COVID-19 and neurological disorders. J Neurol Neurosurg Psychiatry. 2020; 91(8):811-812. PMC: 7299654. DOI: 10.1136/jnnp-2020-323667. View

15.

Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B . Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021; 384(23):2187-2201. PMC: 8220996. DOI: 10.1056/NEJMoa2101544. View

16.

Rowlands S, Hooper R, Hughes R, Burney P . The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol. 2002; 9(1):63-7. DOI: 10.1046/j.1468-1331.2002.00343.x. View

17.

Sejvar J, Kohl K, Gidudu J, Amato A, Bakshi N, Baxter R . Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2010; 29(3):599-612. DOI: 10.1016/j.vaccine.2010.06.003. View

18.

Simas C, Munoz N, Arregoces L, Larson H . HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia. Hum Vaccin Immunother. 2018; 15(1):163-166. PMC: 6363158. DOI: 10.1080/21645515.2018.1511667. View

19.

Ghosh R, Dubey S, Roy D, Mandal A, Naga D, Benito-Leon J . Focal onset non-motor seizure following COVID-19 vaccination: A mere coincidence?. Diabetes Metab Syndr. 2021; 15(3):1023-1024. PMC: 8105133. DOI: 10.1016/j.dsx.2021.05.003. View

20.

Li-Kim-Moy J, Booy R . The manufacturing process should remain the focus for severe febrile reactions in children administered an Australian inactivated influenza vaccine during 2010. Influenza Other Respir Viruses. 2015; 10(1):9-13. PMC: 4687502. DOI: 10.1111/irv.12337. View